Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Esophageal Neoplasms 4Nasopharyngeal Carcinoma 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Head and Neck Neoplasms 2Stomach Neoplasms 1Resectable Pancreatic Cancer 1Penile Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Glioma 1Glioblastoma 1Esophageal 1Diffuse Intrinsic Pontine Glioma 1Colorectal Neoplasms 1Advanced and/or Metastatic Solid Tumours 1Advanced Esophageal 1Adenocarcinoma 1

Interventions

Radiotherapy 5Temozolomide 4Radiation 3Irinotecan 3Bevacizumab 3ribociclib 2abemaciclib 2Vorinostat 2Mebendazole 2Everolimus 2Dasatinib 2vandetanib 1temsirolimus 1sargramostim 1reolysin 1pembrolizumab 1ovex 1nimotuzumab 1irinotecan sucrosofate 1dinutuximab 1crenolanib 1adavosertib 1Vincristine 1Valproic Acid 1Sirolimus 1Re-Irradiation 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation Dose Hypofractionation 1Piperazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Diffuse Intrinsic Pontine Glioma × nimotuzumab × Clear all
NCT00600054 2011-07-06

Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma

YM BioSciences

Phase 2 Completed
44 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡